期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Cloning identification and functional analysis of human IL-17A promoter
1
作者 ming-jie hu Shou-Wei Wu +6 位作者 Mei-Li Wei Jun Xi Lu Wang Yu-Ze Han Bi-Kui Tang Qiang Fang Li Xu 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第8期755-758,共4页
Objective: To conduct the cloning identification and characterization of the sequence of human IL-17 A promoter so as to analyze the regulatory mechanism of the gene expression of IL-17. Methods: First of all, the pot... Objective: To conduct the cloning identification and characterization of the sequence of human IL-17 A promoter so as to analyze the regulatory mechanism of the gene expression of IL-17. Methods: First of all, the potential promoter region of IL-17 A was found by means of the bioinformatics methods. Then, it was cloned into the reporter vector with PCR technique. Finally, the activity of the test promoter was determined by dual luciferase reporter system. Results: Two transcriptional start points of the upper region, 600 bp and 1000 bp, of IL-17 A were obtained by PCR clone and proved to have certain activities by dual luciferase reporter system. Also, they could be activated by IL-17 A activator STAT3, which could start the expression of the reported gene. Conclusions: Clone established the regulatory region of human IL-17 A promoter, which provided bases to the subsequent function research. 展开更多
关键词 IL-17A PROMOTER CLONE FUNCTIONAL analysis
下载PDF
康复新液治疗胃溃疡的疗效观察及对VEGF、ERK12水平的影响 被引量:2
2
作者 周文荣 胡明杰 王坚迪 《世界华人消化杂志》 CAS 2023年第1期28-34,共7页
背景康复新液是一种可通利血脉、养阴生肌的中成药物制剂,可改善微循环,促进组织黏膜修复,对溃疡病症具有显著疗效.基于这一药效,本研究将其应用于胃溃疡的治疗,进一步分析其对胃溃疡的修复作用.目的探讨康复新液联合常规西药治疗胃溃... 背景康复新液是一种可通利血脉、养阴生肌的中成药物制剂,可改善微循环,促进组织黏膜修复,对溃疡病症具有显著疗效.基于这一药效,本研究将其应用于胃溃疡的治疗,进一步分析其对胃溃疡的修复作用.目的探讨康复新液联合常规西药治疗胃溃疡的疗效观察及对血管内皮生长因子(vascular endothelial growth factor,VEGF)、细胞外调节蛋白激酶1/2(extracellular regulated protein kinase 1/2,ERK1/2)、水平的影响.方法前瞻性选取2021-01/2021-08我院48例胃溃疡患者作为研究对象,随机分为两组,各24例.对照组采取常规治疗+安慰剂;于此基础上,观察组予以康复新液治疗,疗程8 wk.观察两组临床效果、治疗前后黏膜微血管形态、血清指标[ERK1/2、VEGF、前列腺素E2(prostaglandin E2,PGE_(2))]、免疫应答T淋巴细胞亚群CD3+、CD4+、CD4+/CD8+水平、再生黏膜组织学成熟度及胃液pH值,记录不良反应发生率及复发率.结果观察组临床总有效率95.83%高于对照组66.67%(P<0.05);观察组规则微血管网比例高于对照组(P<0.05);观察组治疗后VEGF、ERK1/2、PGE_(2)水平高于对照组(P<0.05);观察组治疗后CD3+、CD4+、CD4+/CD8+均高于对照组(P<0.05);观察组胶原纤维沉积面积、Ⅰ/Ⅱ型胶原蛋白比值、羟脯氨酸含量及胃液pH值均高于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义,观察组3 mo复发率4.17%低于对照组33.33%(P<0.05).结论康复新液联合常规药物治疗胃溃疡,可显著提高临床疗效,促进溃疡愈合,降低复发风险,且不会明显增加药物不良反应. 展开更多
关键词 康复新液 胃溃疡 免疫应答
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部